Functional: Pharmacological Management of LUTS: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 423: | Line 423: | ||
*'''Most common (4):''' | *'''Most common (4):''' | ||
*# '''Reduced volume of ejaculate''' (absolute risk difference 4%) | *# '''<span style="color:#ff0000">Reduced volume of ejaculate</span>''' (absolute risk difference 4%) | ||
*# '''Erectile dysfunction''' (4%) | *# '''<span style="color:#ff0000">Erectile dysfunction</span>''' (4%) | ||
*# '''Loss of libido''' (3%) | *# '''<span style="color:#ff0000">Loss of libido</span>''' (3%) | ||
*# '''Gynecomastia''' (2%) | *# '''<span style="color:#ff0000">Gynecomastia</span>''' (2%) | ||
===== Other benefits of 5-ARIs (4): ===== | ===== Other benefits of 5-ARIs (4): ===== | ||